Cargando…
Extensive experience of disease control with gefitinib and the role of prognostic markers
Traditionally, the efficacy of an anticancer agent has been measured by response rate. With the development of biological molecular-targeted agents, which have a different mechanism of action from conventional agents, it may be appropriate to consider alternative criteria that reflect the positive e...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750245/ https://www.ncbi.nlm.nih.gov/pubmed/14661046 http://dx.doi.org/10.1038/sj.bjc.6601476 |